European Pharmaceutical Review

JANUARY 11, 2024

The current medications (opioid and non-opioid) often force the patients to make an unfortunate choice between efficacy and debilitating side effects, leading to a cycling through multiple different therapies and suboptimal treatment response. 2017; 6(S1):1–3. Neuropathic pain: The scope of the problem. Pain and Therapy. Internet] NIH.

Medicine 102

Medicine Pharmacology Management Side effects 102

Pharmaceutical Technology

NOVEMBER 17, 2022

This marks the first update to NICE’s endometriosis guidelines since 2017, representing a huge milestone for patients and practitioners alike. This delay in diagnosis ultimately leads to disease progression and associated complications, such as chronic pelvic pain and infertility, which greatly affects the patients’ quality of life.

Management 102

Management Pharmacology Side effects Patients 102

Clarivate

SEPTEMBER 11, 2024

The pathophysiology of Alzheimer’s is complex and involves multiple mechanisms, including extracellular deposition of amyloid-β (Aβ) plaques and intracellular formation of neurofibrillary tangles (NFT) of tau, causing progressive neuronal loss and atrophy (Counts, 2017). Abbreviations: AD, Alzheimer’s disease; MCI, mild cognitive impairment.

Food and Drug Administration 59

Food and Drug Administration Pharmacology Food FDA 59

European Pharmaceutical Review

JULY 27, 2023

Cardiovascular diseases are the leading cause of death globally with over 18.5 Cardiovascular diseases are the leading cause of death globally with over 18.5 Meta‑analyses of these trials have shown that the therapy is safe and can lead to a reduction in incidences of death and recurrent myocardial infarction. to 1 percent).

Pharmacology 98

Pharmacology Manufacturing Leads Patients 98

Pharmaceutical Technology

FEBRUARY 8, 2023

Blank acknowledged that in many cases, an exclusively paediatric patient population could lead to difficulties with drawing consent for early phase trials. Since the first approval in 2017, the FDA’s Office of Tissue and Advanced Therapies (OTAT) has approved 27 cell and gene therapies.

FDA 105

FDA Patients Pharmacology Pharmaceutical 105

Pharmaceutical Technology

NOVEMBER 3, 2022

This is due to aging populations around the world, which leads to an increased risk of such conditions, explains Craig Beavers, PhD, assistant professor at the University of Kentucky’s College of Pharmacy in Lexington. Also, substitution can lead to further shortages, he adds.

Medicine 111

Medicine Manufacturing Pharmacology Healthcare 111

Clarivate

FEBRUARY 28, 2023

Degeneration of the retinal ganglion cells causes rapidly progressing vision loss, leading to permanent (non-painful) blindness within a year. 9; 9/2017; p447; DOI:10.1016/j.je.2017.02.001 9; 9/2017; p447; DOI:10.1016/j.je.2017.02.001 Frontiers in Pharmacology; 13:1089033; DOI: 10.3389/fphar.2022.1089033

Prescription 98

Prescription Patients Pharmacology Healthcare 98